SCHEMBL18326533

SCHEMBL18326533

CC(C)c1ccc(CC[Si](C)(C)C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.45
ALDH1A1 P00352 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
FKBP1A P62942 1/20 0.41
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
DHFR P00374 1/20 0.40
MAOB P27338 1/20 0.40
HTR1D P28221 1/20 0.40
HTR1B P28222 1/20 0.40
LMNA P02545 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
EPHX1 P07099 1/20 0.38
MAPT P10636 2/20 0.38
UCHL3 P15374 2/20 0.38
PYCR1 P32322 1/20 0.38
KDM4E B2RXH2 1/20 0.38
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15952484 0.83 ESR1 (0.40) LMNAKDM4E
SCHEMBL10729588 0.81 IDO1 (0.56) IDO1ALDH1A1L3MBTL1FKBP1ARAB9A
SCHEMBL16021731 0.79 IDO1 (0.47) IDO1ALDH1A1L3MBTL1FKBP1ARAB9A
SCHEMBL3211356 0.77 GFER (0.59) ALDH1A1RAB9ANPC1MAOBSMN1; SMN2
SCHEMBL2222047 0.77 CA2 (0.52) IDO1ALDH1A1L3MBTL1FKBP1ARAB9A
SCHEMBL24602755 0.75 CYP1A2 (0.52) IDO1ALDH1A1L3MBTL1RAB9ANPC1
SCHEMBL10140562 0.75 IDO1 (0.50) IDO1ALDH1A1L3MBTL1FKBP1ARAB9A
SCHEMBL17722492 0.75 LPL (0.46) ALDH1A1L3MBTL1RAB9ANPC1HTR1D
SCHEMBL597719 0.75 IDO1 (0.50) IDO1ALDH1A1L3MBTL1FKBP1AKMT2A
SCHEMBL11745515 0.74 CYP4A11 (0.47) IDO1ALDH1A1L3MBTL1FKBP1ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160367693-A1 Selective Arylation of Dichalcogenides in Biomolecules NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160367693-A1 Selective Arylation of Dichalcogenides in Biomolecules SCLY, SELENOI, TPO IDO1 960/4885ALDH1A1 3721/4885L3MBTL1 2233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.